OICR research team awarded $2.4 million to facilitate precision medicine for early-stage breast cancer

Bridging the GAPP: Bringing new diagnostic tests to patients

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Dr. John Bartlett discusses why new retrospective breast cancer study could lead to better diagnosis and treatment for patients

New retrospective study aims to identify mutations to better diagnose breast cancer in the future